ﺳپيرونولاكتون تيڤع ١٠٠ ملغ

Country: Իսրայել

language: արաբերեն

source: Ministry of Health

active_ingredient:

SPIRONOLACTONE 100 MG

MAH:

TEVA PHARMACEUTICAL INDUST.LTD

ATC_code:

C03DA01

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

therapeutic_group:

SPIRONOLACTONE

therapeutic_indication:

Edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. Essential hypertention. Primary hyperaldostronism. Hypokalemia.

authorization_date:

2011-11-01